Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein.
about
Membrane transporters in drug developmentN-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrierEffects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography.A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PETSynthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor.Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications.Drug interactions at the blood-brain barrier: fact or fantasy?P-glycoprotein related drug interactions: clinical importance and a consideration of disease states.Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Efflux pump-mediated resistance in chemotherapy.The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.
P2860
Q29616802-3C67A737-9339-48EE-9751-2AC6A645D728Q33891067-8A630A60-CC23-46E2-ACE6-3C8FBB8FC81DQ34571054-24A4B73D-6275-45F3-941D-F5A788C88CF1Q35831488-BCD25069-DE91-446E-8AE1-D0CD28B1AAF0Q36049576-9239408F-01A7-4436-BAA8-55D2B52E037BQ36949068-3269B92D-EE7A-4933-8161-A96AD1B5A7D3Q36949086-F1250909-D98C-4602-BB51-10F51C24D814Q37353400-206AC2F5-780B-4E15-94D6-9E82B5A5692BQ37362486-5FC2852E-5D0B-4A6B-B5C4-9F28E0D6439DQ37732337-36576194-E74F-4F6D-A847-9F31FCB31922Q37855817-E2E17C17-FCCC-4F7C-932A-9C26DD56C02FQ38084554-286F11C4-DB5D-4254-AEA4-0C8FDA213476Q43069428-721F038F-6C6D-47E5-B5D1-5CBB0EB94BA8
P2860
Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@en
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@nl
type
label
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@en
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@nl
prefLabel
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@en
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@nl
P2093
P921
P1433
P1476
Tariquidar, a selective P-glyc ...... of lymphocyte P-glycoprotein.
@en
P2093
Alastair J J Wood
Daniel Kurnik
Gbenga G Sofowora
Grant R Wilkinson
John P Donahue
Usha B Nair
P304
P356
10.1097/ALN.0B013E31818D8F28
P407
P577
2008-12-01T00:00:00Z